Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maryam A.Z. El-Attar"'
Autor:
Nayera W. Hassan, Ahmed Sabt, Maryam A.Z. El-Attar, Mikko Ora, Alaa El-Din A. Bekhit, Kikuko Amagase, Adnan A. Bekhit, Ahmed S.F. Belal, Perihan A. Elzahhar
Publikováno v:
European Journal of Medicinal Chemistry. 253:115333
Autor:
Abeer E. Abdel Wahab, Ibrahim A. Abdelwahab, Rasha Y. Elbayaa, Soad A.M. El-Hawash, Maryam A.Z. El-Attar, Omaima G. Shaaban, Nargues S. Habib
Publikováno v:
Bioorganic Chemistry. 76:437-448
Development of new antimicrobial agents is a good solution to overcome drug-resistance problems. From this perspective, new quinoxaline derivatives bearing various bioactive heterocyclic moieties (thiadiazoles, oxadiazoles, pyrazoles and thiazoles) w
Autor:
Soad Am El Hawash, Ashraf M Omar, Maha A El Demellawy, Abeer E. Abdel Wahab, Maryam A.Z. El-Attar, Heba A. Abd El Razik, Aly A. Hazzaa
Publikováno v:
Future medicinal chemistry. 11(13)
Aim: Cyclooxygenase-2 (COX-2) inhibition and scavenging-free radicals are important targets in cancer treatment. Materials & methods: Sulfanylpyrimidines and triazolopyrimidines were synthesized and evaluated as anticancer and antioxidant COX-1/2 inh
Autor:
Soad A.M. El-Hawash, Maryam A.Z. El-Attar, Abeer E. Abdel Wahab, Ibrahim A. Abdelwahab, Nargues S. Habib, Omaima G. Shaaban, Rasha Y. Elbayaa
Publikováno v:
Future medicinal chemistry. 10(18)
Aim: The development of a new class of antimicrobial agents is the optimal lifeline to scrap the escalating jeopardy of drug resistance. Experimental: This study aims to design and synthesize a series of pyrazolo-1,2,4-triazolo[4,3-a]quinoxalines, to